A recent study in small cell lung cancer identified a link between EMT and resistance to PARP inhibitors in that disease setting [34] and PARP-1 has been shown to regulate EMT in prostate cancer models through regulation of TGFβ signalling and changes in levels of ZEB1 [35]. This evidence concerns the gene ZEB1 and small cell lung carcinoma.